GB 1886.165-2015
HG/T 5709\uff5e5712-2020
GB 1886.128-2015
32018R0243
\u4e2d\u534e\u4eba\u6c11\u5171\u548c\u56fd\u536b\u751f\u90e8\u516c\u544a2011\u5e74\u7b2c8\u53f7-40-2011
QB/T 4817-2015
Fragrance-3,3-dimethyl-5-(2,2,3-trimethyl-3cyclopenten-1-yl)-4-penten-2-ol
\u4e2d\u534e\u4eba\u6c11\u5171\u548c\u56fd\u536b\u751f\u90e8\u516c\u544a2011\u5e74\u7b2c8\u53f7-41-2011
32018R0245
HG/T 5916-2021
T/FSI 079-2022
T/CPUIA 0004-2023
T/CAFFCI 31-2019
USP f100681
(Z)-3-Hexenyl 2-Methylbutyrate
USP f101211
3,4-Dimethyl 1,2-Cyclopentandione
32008H0472
32018D2013
32016R0486
32016R0001
Commission Regulation (EU) 2016/1 of 3 December 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, boscalid, cyazofamid, cyromazine, dazomet, dithiocarbamates, fluazifop-P, mepanipyrim, metrafenone, picloram, propamocarb, pyridaben, pyriofenone, sulfoxaflor, tebuconazole, tebufenpyrad and thiram in or on certain products (Text with EEA rel
32013R0251